asthma

Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma Michael E. Wechsler, John M. Kelley, Ingrid O.E. Boyd, Stefanie Dutile, Gautham Marigowda, Irving Kirsch, Elliot Israel, Ted J. Kaptchuk Published July 14, 2011 [Line breaks added] Background In prospective...

Risk of long covid in patients with pre-existing chronic respiratory diseases: a systematic review and meta-analysis Paul Terry; Eric Heidel; Alexandria Q Wilson; Rajiv Dhand BACKGROUND An estimated 10–30% of people with COVID-19 experience debilitating long-term symptoms or long covid...

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

Thousands miss out on vital asthma jabs as GPs don't know they exist

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study Summary Background Stepwise intensification of inhaled corticosteroids (ICS) is routine for severe...

A chilling account by Robert Cockburn, an Australian journalist, of how he was harmed by unapproved experimental devices in an asthma trial at Sydney University’s Woolcock Institute of Medical Research. He sustained long-term respiratory and neurological injuries from one of the devices. When...

No idea where to put this otherwise as it's a direct consequence of the pandemic and this is preliminary data, but what it suggests is too massive to ignore, especially as it challenges long-held dogma.

May be of use to people living with allergies, eczema & asthma https://www.allergyuk.org/get-help/resources/1225-coronavirus-and-allergy-faqs